Selected research
Market Structure
Global Syndromic Diagnostic Test Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Syndromic Diagnostic Test market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for Syndromic Diagnostic Test is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Syndromic Diagnostic Test is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Syndromic Diagnostic Test is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Syndromic Diagnostic Test is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Syndromic Diagnostic Test include Abbott, Hologic, Applied BioCode, Danaher, Diagenode, Curetis, Bio-Rad, DiaSorin and bioMérieux, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global Syndromic Diagnostic Test market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Syndromic Diagnostic Test and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Syndromic Diagnostic Test revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Syndromic Diagnostic Test market size, projected growth trends, production technologies, key applications, and end-use industries.
Syndromic Diagnostic Test Segment by Company
Abbott
Hologic
Applied BioCode
Danaher
Diagenode
Curetis
Bio-Rad
DiaSorin
bioMérieux
QIAGEN
Syndromic Diagnostic Test Segment by Type
Nucleic Acid Extraction Test
Polymerase Chain Reaction (PCR) Test
Others
Syndromic Diagnostic Test Segment by Application
Hospital
Laboratory
Research Institution
Others
Syndromic Diagnostic Test Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Syndromic Diagnostic Test market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Syndromic Diagnostic Test and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Syndromic Diagnostic Test.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Syndromic Diagnostic Test in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Syndromic Diagnostic Test industry.
Chapter 3: Detailed analysis of Syndromic Diagnostic Test companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Syndromic Diagnostic Testrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Nucleic Acid Extraction Test
- Polymerase Chain Reaction (PCR) Test
- Others
Applications
- Hospital
- Laboratory
- Research Institution
- Others
Companies covered
- Abbott
- Hologic
- Applied BioCode
- Danaher
- Diagenode
- Curetis
- Bio-Rad
- DiaSorin
- bioMérieux
- QIAGEN
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Syndromic Diagnostic Test Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Nucleic Acid Extraction Test
- 1.2.3 Polymerase Chain Reaction (PCR) Test
- 1.2.4 Others
- 1.3 Market Analysis by Application
- 1.3.1 Global Syndromic Diagnostic Test Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Hospital
- 1.3.3 Laboratory
- 1.3.4 Research Institution
- 1.3.5 Others
- 1.4 Global Market Growth Prospects
- 1.5 Global Syndromic Diagnostic Test Growth Trends by Region
- 1.5.1 Global Syndromic Diagnostic Test Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Syndromic Diagnostic Test Market Size by Region (2021-2026)
- 1.5.3 Syndromic Diagnostic Test Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Syndromic Diagnostic Test Market Dynamics
- 2.1 Syndromic Diagnostic Test Industry Trends
- 2.2 Syndromic Diagnostic Test Industry Drivers
- 2.3 Syndromic Diagnostic Test Industry Opportunities and Challenges
- 2.4 Syndromic Diagnostic Test Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Syndromic Diagnostic Test Revenue by Company (2021-2026)
- 3.2 Global Syndromic Diagnostic Test Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Syndromic Diagnostic Test Key Company Head office and Area Served
- 3.4 Global Syndromic Diagnostic Test Company, Product Type & Application
- 3.5 Global Syndromic Diagnostic Test Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Syndromic Diagnostic Test Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Syndromic Diagnostic Test Players Market Share by Revenue in 2025
- 3.6.3 2025 Syndromic Diagnostic Test Tier 1, Tier 2, and Tier 3
4 Syndromic Diagnostic Test Market by Type
- 4.1 Global Syndromic Diagnostic Test Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Syndromic Diagnostic Test Market Size by Type (2021-2032)
- 4.3 Global Syndromic Diagnostic Test Market Size Share by Type (2021-2032)
5 Syndromic Diagnostic Test Market by Application
- 5.1 Global Syndromic Diagnostic Test Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Syndromic Diagnostic Test Market Size by Application (2021-2032)
- 5.3 Global Syndromic Diagnostic Test Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 Abbott
- 6.1.1 Abbott Company Information
- 6.1.2 Abbott Business Overview
- 6.1.3 Abbott Syndromic Diagnostic Test Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 Abbott Syndromic Diagnostic Test Product Portfolio
- 6.1.5 Abbott Recent Developments
- 6.2 Hologic
- 6.2.1 Hologic Company Information
- 6.2.2 Hologic Business Overview
- 6.2.3 Hologic Syndromic Diagnostic Test Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 Hologic Syndromic Diagnostic Test Product Portfolio
- 6.2.5 Hologic Recent Developments
- 6.3 Applied BioCode
- 6.3.1 Applied BioCode Company Information
- 6.3.2 Applied BioCode Business Overview
- 6.3.3 Applied BioCode Syndromic Diagnostic Test Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 Applied BioCode Syndromic Diagnostic Test Product Portfolio
- 6.3.5 Applied BioCode Recent Developments
- 6.4 Danaher
- 6.4.1 Danaher Company Information
- 6.4.2 Danaher Business Overview
- 6.4.3 Danaher Syndromic Diagnostic Test Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 Danaher Syndromic Diagnostic Test Product Portfolio
- 6.4.5 Danaher Recent Developments
- 6.5 Diagenode
- 6.5.1 Diagenode Company Information
- 6.5.2 Diagenode Business Overview
- 6.5.3 Diagenode Syndromic Diagnostic Test Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 Diagenode Syndromic Diagnostic Test Product Portfolio
- 6.5.5 Diagenode Recent Developments
- 6.6 Curetis
- 6.6.1 Curetis Company Information
- 6.6.2 Curetis Business Overview
- 6.6.3 Curetis Syndromic Diagnostic Test Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 Curetis Syndromic Diagnostic Test Product Portfolio
- 6.6.5 Curetis Recent Developments
- 6.7 Bio-Rad
- 6.7.1 Bio-Rad Company Information
- 6.7.2 Bio-Rad Business Overview
- 6.7.3 Bio-Rad Syndromic Diagnostic Test Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 Bio-Rad Syndromic Diagnostic Test Product Portfolio
- 6.7.5 Bio-Rad Recent Developments
- 6.8 DiaSorin
- 6.8.1 DiaSorin Company Information
- 6.8.2 DiaSorin Business Overview
- 6.8.3 DiaSorin Syndromic Diagnostic Test Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 DiaSorin Syndromic Diagnostic Test Product Portfolio
- 6.8.5 DiaSorin Recent Developments
- 6.9 bioMérieux
- 6.9.1 bioMérieux Company Information
- 6.9.2 bioMérieux Business Overview
- 6.9.3 bioMérieux Syndromic Diagnostic Test Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 bioMérieux Syndromic Diagnostic Test Product Portfolio
- 6.9.5 bioMérieux Recent Developments
- 6.10 QIAGEN
- 6.10.1 QIAGEN Company Information
- 6.10.2 QIAGEN Business Overview
- 6.10.3 QIAGEN Syndromic Diagnostic Test Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 QIAGEN Syndromic Diagnostic Test Product Portfolio
- 6.10.5 QIAGEN Recent Developments
7 North America
- 7.1 North America Syndromic Diagnostic Test Market Size (2021-2032)
- 7.2 North America Syndromic Diagnostic Test Market Size by Type
- 7.2.1 North America Syndromic Diagnostic Test Market Size by Type (2021-2026)
- 7.2.2 North America Syndromic Diagnostic Test Market Size by Type (2027-2032)
- 7.2.3 North America Syndromic Diagnostic Test Market Share by Type (2021-2032)
- 7.3 North America Syndromic Diagnostic Test Market Size by Application
- 7.3.1 North America Syndromic Diagnostic Test Market Size by Application (2021-2026)
- 7.3.2 North America Syndromic Diagnostic Test Market Size by Application (2027-2032)
- 7.3.3 North America Syndromic Diagnostic Test Market Share by Application (2021-2032)
- 7.4 North America Syndromic Diagnostic Test Market Size by Country
- 7.4.1 North America Syndromic Diagnostic Test Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Syndromic Diagnostic Test Market Size by Country (2021-2026)
- 7.4.3 North America Syndromic Diagnostic Test Market Size by Country (2027-2032)
- 7.4.4 North America Syndromic Diagnostic Test Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Syndromic Diagnostic Test Market Size (2021-2032)
- 8.2 Europe Syndromic Diagnostic Test Market Size by Type
- 8.2.1 Europe Syndromic Diagnostic Test Market Size by Type (2021-2026)
- 8.2.2 Europe Syndromic Diagnostic Test Market Size by Type (2027-2032)
- 8.2.3 Europe Syndromic Diagnostic Test Market Share by Type (2021-2032)
- 8.3 Europe Syndromic Diagnostic Test Market Size by Application
- 8.3.1 Europe Syndromic Diagnostic Test Market Size by Application (2021-2026)
- 8.3.2 Europe Syndromic Diagnostic Test Market Size by Application (2027-2032)
- 8.3.3 Europe Syndromic Diagnostic Test Market Share by Application (2021-2032)
- 8.4 Europe Syndromic Diagnostic Test Market Size by Country
- 8.4.1 Europe Syndromic Diagnostic Test Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Syndromic Diagnostic Test Market Size by Country (2021-2026)
- 8.4.3 Europe Syndromic Diagnostic Test Market Size by Country (2027-2032)
- 8.4.4 Europe Syndromic Diagnostic Test Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Syndromic Diagnostic Test Market Size (2021-2032)
- 9.2 China Syndromic Diagnostic Test Market Size by Type
- 9.2.1 China Syndromic Diagnostic Test Market Size by Type (2021-2026)
- 9.2.2 China Syndromic Diagnostic Test Market Size by Type (2027-2032)
- 9.2.3 China Syndromic Diagnostic Test Market Share by Type (2021-2032)
- 9.3 China Syndromic Diagnostic Test Market Size by Application
- 9.3.1 China Syndromic Diagnostic Test Market Size by Application (2021-2026)
- 9.3.2 China Syndromic Diagnostic Test Market Size by Application (2027-2032)
- 9.3.3 China Syndromic Diagnostic Test Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Syndromic Diagnostic Test Market Size (2021-2032)
- 10.2 Asia Syndromic Diagnostic Test Market Size by Type
- 10.2.1 Asia Syndromic Diagnostic Test Market Size by Type (2021-2026)
- 10.2.2 Asia Syndromic Diagnostic Test Market Size by Type (2027-2032)
- 10.2.3 Asia Syndromic Diagnostic Test Market Share by Type (2021-2032)
- 10.3 Asia Syndromic Diagnostic Test Market Size by Application
- 10.3.1 Asia Syndromic Diagnostic Test Market Size by Application (2021-2026)
- 10.3.2 Asia Syndromic Diagnostic Test Market Size by Application (2027-2032)
- 10.3.3 Asia Syndromic Diagnostic Test Market Share by Application (2021-2032)
- 10.4 Asia Syndromic Diagnostic Test Market Size by Country
- 10.4.1 Asia Syndromic Diagnostic Test Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Syndromic Diagnostic Test Market Size by Country (2021-2026)
- 10.4.3 Asia Syndromic Diagnostic Test Market Size by Country (2027-2032)
- 10.4.4 Asia Syndromic Diagnostic Test Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Syndromic Diagnostic Test Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Syndromic Diagnostic Test Market Size by Type
- 11.2.1 South America, Middle East & Africa Syndromic Diagnostic Test Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Syndromic Diagnostic Test Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Syndromic Diagnostic Test Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Syndromic Diagnostic Test Market Size by Application
- 11.3.1 South America, Middle East & Africa Syndromic Diagnostic Test Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Syndromic Diagnostic Test Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Syndromic Diagnostic Test Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Syndromic Diagnostic Test Market Size by Country
- 11.4.1 South America, Middle East & Africa Syndromic Diagnostic Test Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Syndromic Diagnostic Test Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Syndromic Diagnostic Test Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Syndromic Diagnostic Test Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst